These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 31727575

  • 1. The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients.
    Sukkha S, Chindavijak B, Nosoongnoen W, Phakdeekitchareon B, Kitiyakara C, Sumethkul V.
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):139-144. PubMed ID: 31727575
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
    Marquet P, Albano L, Woillard JB, Rostaing L, Kamar N, Sakarovitch C, Gatault P, Buchler M, Charpentier B, Thervet E, Cassuto E.
    Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
    [Abstract] [Full Text] [Related]

  • 4. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
    Sukkha S, Suansanae T, Iamrahong P, Wiwattanathum P.
    Transplant Proc; 2020 Apr; 52(3):775-779. PubMed ID: 32143870
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH, Lee SD, Kim YK, Park SJ.
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [Abstract] [Full Text] [Related]

  • 10. Conversion From a Twice-Daily to a Once-Daily Tacrolimus Formulation in Kidney Transplant Recipients.
    Kamińska D, Poznański P, Kuriata-Kordek M, Zielińska D, Mazanowska O, Kościelska-Kasprzak K, Krajewska M.
    Transplant Proc; 2020 Oct; 52(8):2288-2293. PubMed ID: 32247597
    [Abstract] [Full Text] [Related]

  • 11. Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy.
    Min SI, Ha J, Kang HG, Ahn S, Park T, Park DD, Kim SM, Hong HJ, Min SK, Ha IS, Kim SJ.
    Am J Transplant; 2013 Aug; 13(8):2191-7. PubMed ID: 23734831
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.
    Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
    [Abstract] [Full Text] [Related]

  • 13. Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation.
    Stifft F, Stolk LM, Undre N, van Hooff JP, Christiaans MH.
    Transplantation; 2014 Apr 15; 97(7):775-80. PubMed ID: 24686426
    [Abstract] [Full Text] [Related]

  • 14. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
    Ruangkanchanasetr P, Sanohdontree N, Supaporn T, Sathavarodom N, Satirapoj B.
    Ann Transplant; 2016 Dec 16; 21():765-774. PubMed ID: 27980321
    [Abstract] [Full Text] [Related]

  • 15. Conversion from twice-daily to once-daily tacrolimus does not reduce intrapatient variability in tacrolimus exposure.
    Shuker N, Cadogan M, van Gelder T, Roodnat JI, Kho MM, Weimar W, Hesselink DA.
    Ther Drug Monit; 2015 Apr 16; 37(2):262-9. PubMed ID: 25265255
    [Abstract] [Full Text] [Related]

  • 16. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation.
    Niioka T, Satoh S, Kagaya H, Numakura K, Inoue T, Saito M, Narita S, Tsuchiya N, Habuchi T, Miura M.
    Transplantation; 2012 Nov 27; 94(10):1013-9. PubMed ID: 23073468
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
    Ma MK, Kwan LP, Mok MM, Yap DY, Tang CS, Chan TM.
    Ren Fail; 2013 Aug 27; 35(7):942-5. PubMed ID: 23815459
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Once- versus twice-daily tacrolimus: are the formulations truly equivalent?
    Barraclough KA, Isbel NM, Johnson DW, Campbell SB, Staatz CE.
    Drugs; 2011 Aug 20; 71(12):1561-77. PubMed ID: 21861541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.